Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
-7.81%
1 month
59.46%
YTD
-71.9%
1 year
-77.31%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
31 October 23 |
Firebrick Receives $1.81m R&D Tax Incentive
×
Firebrick Receives $1.81m R&D Tax Incentive |
31 October 22 |
September 2022 Quarterly Activity Report & Appendix 4C
×
September 2022 Quarterly Activity Report & Appendix 4C |
31 October 22 |
Firebrick Update on Nasodine Phase 3 Trial
×
Firebrick Update on Nasodine Phase 3 Trial |
31 May 23 |
Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment
×
Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment |
29 November 23 |
Nasodine COVID-19 Patent Granted in South Africa
×
Nasodine COVID-19 Patent Granted in South Africa |
29 May 23 |
Update on Nasodine AAT Appeal Timetable
×
Update on Nasodine AAT Appeal Timetable |
29 June 23 |
Firebrick Update on AAT Schedule
×
Firebrick Update on AAT Schedule |
29 July 22 |
June 2022 Quarterly Activity Report & Appendix 4C
×
June 2022 Quarterly Activity Report & Appendix 4C |
29 August 23 |
Appendix 4E & Annual Report FY23
×
Appendix 4E & Annual Report FY23 |
29 August 23 |
Corporate Governance Statement
×
Corporate Governance Statement |
29 August 23 |
Appendix 4G
×
Appendix 4G |
28 September 22 |
Notice of AGM and Closing Date for Director Nominations
×
Notice of AGM and Closing Date for Director Nominations |
28 March 23 |
Application for quotation of securities - FRE
×
Application for quotation of securities - FRE |
28 March 23 |
Cleansing Notice
×
Cleansing Notice |
28 August 23 |
Response to ASX Price and Volume Query
×
Response to ASX Price and Volume Query |
27 October 23 |
September 2023 Quarterly Activity Report & Appendix 4C
×
September 2023 Quarterly Activity Report & Appendix 4C |
27 July 23 |
June 2023 Quarterly Activity Report & Appendix 4C
×
June 2023 Quarterly Activity Report & Appendix 4C |
26 July 22 |
Firebrick Presents at Euroz Hartleys Healthcare Conference
×
Firebrick Presents at Euroz Hartleys Healthcare Conference |
26 April 22 |
Firebrick starts COVID-19 trial of Nasodine
×
Firebrick starts COVID-19 trial of Nasodine |
26 April 22 |
March 2022 Quarterly Activity Report & Appendix 4C
×
March 2022 Quarterly Activity Report & Appendix 4C |
25 October 22 |
Nasodine Patent Granted in Singapore
×
Nasodine Patent Granted in Singapore |
25 May 22 |
Firebrick Appoints Dr Richard Treagus as Director
×
Firebrick Appoints Dr Richard Treagus as Director |
25 May 22 |
Nasodine Patent Granted in Malaysia
×
Nasodine Patent Granted in Malaysia |
25 May 22 |
Proposed issue of securities - FRE
×
Proposed issue of securities - FRE |
24 November 22 |
Constitution
×
Constitution |
24 November 22 |
Notification regarding unquoted securities - FRE
×
Notification regarding unquoted securities - FRE |
24 November 22 |
Notification regarding unquoted securities - FRE
×
Notification regarding unquoted securities - FRE |
24 November 22 |
Change of Director's Interest Notice - Richard Treagus
×
Change of Director's Interest Notice - Richard Treagus |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.